PATENT CLAIM ANALYSIS

Application Number: 15744448
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "234500"]

Abstract:
The present invention provides indazole and aza indazole compounds of formula (I) or (II) and pharmaceutically acceptable salts thereof, and their use to inhibit IRAK-4 and/or for the treatment of diseases or disorders induced by IRAK-4.

Claim (Index 21):
The compound of any one of  claims 1 - 18 , having the structure of formula (IC): or a pharmaceutically acceptable salt or stereoisomer thereof; wherein Q, B, W, R 2 , and \u2018m\u2019 are as defined in  claim 1 .

Metadata:
- Claim Count in Document: 71.0
- Percentile: 86.0
- Lexical Diversity: 1.23529
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15110309', '15667173', '15111000', '15106073', '13696601']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8116046810994535
- 35 USC 102 Novelty (BERT): 0.576833202567242
- Combined Prediction Score: 0.7881275332462323
- Mean Citation Score: 436.33996800000006
- Max Citation Score: 504.22797
- Similarity Product: 384.004462657553

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test